Clinical Trials Directory

Trials / Completed

CompletedNCT00586781

Study of the Scandinavian Total Ankle Replacement (STAR) for the Treatment of Bilateral Degenerative Ankle Disease

Investigational Device Exemption for the Scandinavian Total Ankle Replacement (STAR) - Bilateral Arm

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Link America, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the safety of the S.T.A.R. device for patients with bilateral disease.

Detailed description

The specific objectives are to show that the safety data of the S.T.A.R. ankle arthroplasty is similar for treatment of single ankle disease (as defined in the pivotal study) and bilateral ankle disease. The bilateral disease may be identified at the time of enrollment or may have progressed after enrollment and treatment of the first ankle in the pivotal study.

Conditions

Interventions

TypeNameDescription
DEVICEScandinavian Total Ankle Replacement (STAR)The device has three parts: two metal bearing surfaces (cobalt-chromium alloy) plates with bars that fit into the bone and one plastic (polyethylene) spacer that moves between the metal plates like a ball bearing. The materials in the S.T.A.R. device are the same materials used in total hip and knee implants.

Timeline

Start date
2001-09-01
Primary completion
2006-12-01
First posted
2008-01-04
Last updated
2008-01-04

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00586781. Inclusion in this directory is not an endorsement.